Compare Novavax Inc (NVAX) vs YieldMax TSLA Option Income Strategy ETF (TSLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while YieldMax TSLA Option Income Strategy ETF trades at $21.86. The key difference: Novavax Inc is trading nearer its 52-week high, YieldMax TSLA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| NVAX | TSLY | |
|---|---|---|
Market Cap | $1.31B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $11.19 | $48.25 |
52-Week Low | $6.22 | $20.49 |
Enterprise Value | $889.30M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About YieldMax TSLA Option Income Strategy ETF
TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →
